Marloes E.C. Broekmans
Cancer Center AmsterdamVrije Universiteit Amsterdam(NL)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Peptidase Inhibition and Analysis, Monoclonal and Polyclonal Antibodies Research, Synthesis and Biological Evaluation, Calcium signaling and nucleotide metabolism
Most-Cited Works
- → Neuroblastoma is composed of two super-enhancer-associated differentiation states(2017)562 cited
- → LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression(2012)384 cited
- → Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification(2012)234 cited
- → A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma(2019)171 cited
- → Monocytes and Granulocytes Reduce CD38 Expression Levels on Myeloma Cells in Patients Treated with Daratumumab(2017)167 cited
- → Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma(2021)157 cited
- → Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab(2020)85 cited
- → T-Cell Characteristics Impact Response and Resistance to T-Cell–Redirecting Bispecific Antibodies in Multiple Myeloma(2024)47 cited
- → CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience(2018)36 cited
- → Preclinical Rationale for Targeting the PD-1/PD-L1 Axis in Combination with a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies(2020)35 cited